Virtual Reality-Based Cognitive Remediation in Schizophrenia and Bipolar Disorder
FULL-MINDSET- Fully Immersive Virtual Reality-based Cognitive Training in Schizophrenia and Bipolar Disorder: a Single Blind Randomized Controlled Trial in a Real-world Setting
This randomized controlled trial aims to evaluate the effectiveness of a virtual reality-based cognitive remediation (VRCR) intervention in improving cognitive performance and psychosocial functioning in individuals with schizophrenia spectrum disorders (SSD) and bipolar disorder (BD).
A total of 80 participants (40 with SSD and 40 with BD) will be randomly assigned in a 1:1 ratio to receive either VRCR or treatment as usual (TAU). The VRCR intervention will be delivered using the CEREBRUM platform and will consist of 45-minute sessions administered twice weekly for 12 weeks under the supervision of trained therapists.
The primary outcomes are changes in cognitive performance and psychosocial functioning, assessed using the MATRICS Consensus Cognitive Battery (MCCB) and the Personal and Social Performance (PSP) scale, respectively. Secondary outcomes include clinical symptom severity, assessed with validated rating scales, and neurobiological correlates, including functional magnetic resonance imaging (fMRI) and genetic biomarkers.
Assessments will be conducted at baseline, at 3 months (post-intervention), and at 6 months (follow-up). fMRI assessments will be conducted at baseline in patients with schizophrenia spectrum disorders, whereas peripheral blood samples for genetic marker analyses will be collected at baseline and at the 3-month follow-up in patients with SSD and BD. This study is expected to provide evidence on the feasibility, acceptability, and effectiveness of VR-based cognitive remediation in SSD and BD, as well as insights into the neurobiological mechanisms underlying cognitive and functional improvements.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Lombardy
-
Brescia, Lombardy, Italia, 25123
- ASST Spedali Civili di Brescia - Department of Mental Health and Addiction Services
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Age ≥ 18 years
- Diagnosis of schizophrenia spectrum disorder or bipolar disorder (DSM-5)
- Clinical stability for at least 3 months
- Ability to provide informed consent
Exclusion Criteria:
- neurological disorders
- intellectual disability
- inability to participate in VR-based interventions due to medical or sensory limitations.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Participants with diagnosis of schizophrenia receiving VRCR
|
Participants in the VRCR group will receive individualized cognitive training using the CEREBRUM platform (IDEGO, Rome, Italy). CEREBRUM is an immersive virtual reality software where the user wearing the viewer sees a virtual environment that can be explored at 360°; it consists of 52 ecologically valid exercises of varying difficulty: 22 belonging to the Memory, and Learning Module, 10 to the Cognitive Estimates Module and 20 to the Attention and Working Memory Module. The difficulty of exercises is adaptable to provide adequately implement scaffolding and errorless learning principles, and the exercises require active interaction with the therapist. The software is compatible with the Oculus Go virtual reality viewer, a device with CE obligation. The program consists of 12 weeks of individual training, delivered twice weekly in 45-minute sessions in a controlled setting, from T0 (baseline) to T1 (3 months after T0). |
|
Comparatore attivo: Participants with diagnosis of schizophrenia receiving standard clinical care
Participants receiving standard clinical care, including pharmacological treatment and case management
|
Standard clinical care including pharmacological treatment and case management according to routine clinical practice.
|
|
Sperimentale: Participants with diagnosis of bipolar disorder receiving VRCR
|
Participants in the VRCR group will receive individualized cognitive training using the CEREBRUM platform (IDEGO, Rome, Italy). CEREBRUM is an immersive virtual reality software where the user wearing the viewer sees a virtual environment that can be explored at 360°; it consists of 52 ecologically valid exercises of varying difficulty: 22 belonging to the Memory, and Learning Module, 10 to the Cognitive Estimates Module and 20 to the Attention and Working Memory Module. The difficulty of exercises is adaptable to provide adequately implement scaffolding and errorless learning principles, and the exercises require active interaction with the therapist. The software is compatible with the Oculus Go virtual reality viewer, a device with CE obligation. The program consists of 12 weeks of individual training, delivered twice weekly in 45-minute sessions in a controlled setting, from T0 (baseline) to T1 (3 months after T0). |
|
Comparatore attivo: Participants with diagnosis of bipolar disorder receiving standard clinical care
Participants receiving standard clinical care, including pharmacological treatment and case management
|
Standard clinical care including pharmacological treatment and case management according to routine clinical practice.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in cognitive performance measured by MATRICS Consensus Cognitive Battery (MCCB) total score
Lasso di tempo: Baseline, 3 months (end of the intervention), and 6 months
|
Cognitive performance will be assessed using the MATRICS Consensus Cognitive Battery (MCCB), a standardized neuropsychological battery evaluating processing speed, attention/vigilance, working memory, verbal learning, visual learning, reasoning/problem solving, and social cognition.
|
Baseline, 3 months (end of the intervention), and 6 months
|
|
Change in psychosocial functioning measured by Personal and Social Performance (PSP) scale
Lasso di tempo: Baseline, 3 months (end of the intervention), and 6 months
|
Psychosocial functioning will be assessed using the Personal and Social Performance (PSP) scale, which evaluates socially useful activities, personal and social relationships, self-care, and disturbing or aggressive behaviors.
|
Baseline, 3 months (end of the intervention), and 6 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Clinical Global Impression (CGI) severity score
Lasso di tempo: Baseline, 3 months (end of the intervention), and 6 months
|
Baseline, 3 months (end of the intervention), and 6 months
|
|
|
Change in Positive and Negative Syndrome Scale (PANSS) total score in participants with schizophrenia spectrum disorders
Lasso di tempo: Baseline, 3 months (end of the intervention), and 6 months
|
Baseline, 3 months (end of the intervention), and 6 months
|
|
|
Change in Brief Negative Symptom Scale (BNSS) total score in participants with schizophrenia spectrum disorders
Lasso di tempo: Baseline, 3 months (end of the intervention), and 6 months
|
Baseline, 3 months (end of the intervention), and 6 months
|
|
|
Change in Hamilton Depression Rating Scale (HAM-D) total score in participants with bipolar disorder
Lasso di tempo: Baseline, 3 months (end of the intervention), and 6 months
|
Baseline, 3 months (end of the intervention), and 6 months
|
|
|
Change in Young Mania Rating Scale (YMRS) total score in participants with bipolar disorder
Lasso di tempo: Baseline, 3 months (end of the intervention), and 6 months
|
Baseline, 3 months (end of the intervention), and 6 months
|
|
|
Neurobiological correlates assessed by functional magnetic resonance imaging (fMRI) in patients with a diagnosis of SSD
Lasso di tempo: Baseline
|
Baseline
|
|
|
Changes in neuroplasticity-related biomarkers (BDNF, VEGF, DYRK1A)
Lasso di tempo: Baseline to 3 months (end of the intervention)
|
Blood samples will be analyzed to assess biomarkers associated with neuroplasticity and cognitive functioning in patients with SSD and BD.
|
Baseline to 3 months (end of the intervention)
|
Collaboratori e investigatori
Investigatori
- Cattedra di studio: Antonio Vita, MD, PhD, Università degli Studi di Brescia
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- FULL-MINDSET
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Disturbo bipolare (BD)
-
Becton, Dickinson and CompanyCompletatoBD SiteRite 9 per l'inserimento VADStati Uniti
-
Becton, Dickinson and CompanyCompletatoBD Prevue II per il posizionamento del catetere endovenoso perifericoStati Uniti
-
University of AarhusReclutamento
-
Ole Köhler-ForsbergGødstrup Hospital; Randers Regional HospitalAttivo, non reclutante
-
First Affiliated Hospital of Zhejiang UniversityReclutamento
-
King's College LondonSouth London and Maudsley NHS Foundation TrustReclutamentoDisturbo bipolare (BD)Regno Unito
-
Centre Hospitalier St AnneNon ancora reclutamento
-
Babes-Bolyai UniversityReclutamentoDisturbo bipolare (BD)Romania
-
National Human Genome Research Institute (NHGRI)CompletatoDisturbo bipolare (BD) | BipolareStati Uniti
-
Shanghai Mental Health CenterReclutamentoControllo sano | Disturbo bipolare (BD)Cina
Prove cliniche su Virtual Reality Cognitive Remediation (VRCR)
-
Cukurova UniversityCompletatoAnsia | Procedure chirurgiche, elettive | Pazienti preoperatoriTacchino
-
Universitat Oberta de CatalunyaMinisterio de Ciencia e Innovación, Spain; European Social FundNon ancora reclutamentoEmpatia | Terapia dell'esposizione alla realtà virtuale | Molestie sessuali | Violenza di genere
-
Berker OkayReclutamentoStress, Psicologico | Ansia | PauraTurchia (Türkiye)
-
October 6 UniversityNon ancora reclutamento
-
Nova Scotia Health AuthorityReclutamentoGlaucoma ad angolo apertoCanada
-
Virginia Commonwealth UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Reclutamento
-
Qilu Hospital of Shandong UniversityNon ancora reclutamento
-
Abby GeerlingsCompletatoAnsia | Rigurgito mitralico | Realta virtuale | Mitraclip | Rigurgito tricuspide (TR) | TriClipOlanda
-
Universidad Rey Juan CarlosCompletatoRealta virtuale | Bobath Terapia | Controllo posturale | Programma di esercizi a casaSpagna
-
George Washington UniversityTerminatoDisturbo vestibolareStati Uniti